Provided by Tiger Trade Technology Pte. Ltd.

Natera

395.56
-5.0900-1.27%
Pre-market: 394.58-0.9800-0.25%04:49 EDT
Volume:2.82M
Turnover:1.11B
Market Cap:56.65B
PE:-288.12
High:401.09
Open:393.02
Low:383.45
Close:400.65
52wk High:437.41
52wk Low:167.99
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.36
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:31.10
PE(LYR):-259.07

Loading ...

Natera, - Announces Signatera Collaboration with Angiox to Assess Nd-ADC Therapy Response

THOMSON REUTERS
·
Aug 27

Natera, - Collaboration Includes Longitudinal Signatera Ctdna Testing for Agx101 Response Monitoring

THOMSON REUTERS
·
Aug 27

Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST

Simply Wall St.
·
Aug 26

Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?

Simply Wall St.
·
Aug 25

Analysts Conflicted on These Healthcare Names: Natera (NTRA), Healthequity (HQY) and CSPC Pharmaceutical Group (OtherCHJTF)

TIPRANKS
·
Aug 24

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)

TIPRANKS
·
Aug 17

Stanley Druckenmiller Ditched These Chip Plays Before the Selloff. Here's How He's Playing the Tech Sector Now.

Dow Jones
·
Aug 17

Natera price target raised to $360 from $290 at Guggenheim

TIPRANKS
·
Aug 17

Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million

Reuters
·
Aug 15

Natera (NTRA) Gets a Buy from Citi

TIPRANKS
·
Aug 14

Natera Price Target Raised to $365.00/Share from $315.00 by Citigroup

Dow Jones
·
Aug 14

Natera, Inc. : Citigroup Raises Target Price to $365 from $315

THOMSON REUTERS
·
Aug 13

Natera Price Target Raised to $350.00/Share from $305.00 by Stephens & Co.

Dow Jones
·
Aug 13

Stephens Keeps Their Buy Rating on Natera (NTRA)

TIPRANKS
·
Aug 12

Piper Sandler Sticks to Its Buy Rating for Natera (NTRA)

TIPRANKS
·
Aug 12

Natera, Inc. : Stephens Raises Target Price to $350 from $305

THOMSON REUTERS
·
Aug 12

Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial

Reuters
·
Aug 12

Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers

THOMSON REUTERS
·
Aug 12

Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249

THOMSON REUTERS
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12